Browsing: Secondary Life Markets
Longevity and Mortality Investor’s coverage of the secondary life markets, including life settlements, equity release, reverse mortgages and life contingent structured settlements.
Two recent litigation cases produced opposite results for the life settlement market.
How durational mortality curves, stochastic A/E analysis and independent audits can strengthen investor confidence and fund sustainability.
Why a different approach might be needed to bring the UK’s secondary life insurance market back to life.
LifeRoc Capital’s Brandon Marz provides his thoughts on the state of the life settlement industry’s secondary market in this month’s Q&A.
Delaware Supreme Court opinion says that the three-year statute of limitations applies to estates seeking to recover the death benefit from a STOLI policy.
Supply and demand dynamics in terms of annuity issuance and the need for reinsurance solutions remains strong.
Kosmos 2026-1 is the seventh asset-backed security issuance since 2019 for the firm and the third in six months.
The UK’s equity release securitisation market has re-emerged in recent years as a tool in a life insurer’s capital optimisation effort.
Greg Winterton caught up with Dr. Joshua Funder, CEO and Managing Director of Household Capital, to discuss the current state of and outlook for the reverse mortgage sector of the Australian securitisation market in this month’s Q&A.
One of the findings from the 2025 ELSA–Conning Life Settlement Investor Sentiment Study was that investors see life settlements sitting in their ‘resilience bucket,’ alongside private credit, infrastructure, and real assets.